Share on:
The assets of Medin Corporation were acquired in December 2016 by Seven Point Equity Partners in a recapitalization transaction. The company is now named Medin Technologies, and will continue to market sterilization cases and trays for the orthopaedic industry.
Mr. Jay Schainholz, former CEO, now serves as company Chairman. Mr. Andy Novotny has been named as Medin’s new CEO. Seven Point completed the recapitalization through an all-equity structure with no outside lenders, and Kinsella Group served as Medin’s financial advisor.
Medin is FDA and ISO 13485 Registered and works with aluminum and stainless steel, as well as thermoformed and machined plastics. Medin’s offerings include:
- Enhanced and extensive engineering resources, manufacturing capabilities and contract manufacturing services
- Integrated and value-added supply chain management solutions
- Complex, customized product development and regulatory support capabilities
- Cost reduction strategies through unified product design for manufacturing
Source: Medin Technologies, Inc.
RELATED ARTICLES
Norwood Medical Appoints Gregg Olson as VP Sales & Marketing
Mar 27 2024 , Julie A. Vetalice
Tapping into the Promising Potential of AI in Orthopedics
Mar 26 2024 , BONEZONE Editors
4 Benefits of Additive Manufacturing Design in the Orthopedic Market
Mar 25 2024 , Paragon Medical
Materials Solutions for Medical Device Instrumentation
Mar 22 2024 , Carpenter Technology